O17-1 Subcutaneous (SC) epcoritamab induces complete responses across R/R B-cell NHL subtypes: Updated dose-escalation data

Martin Hutchings; Rogier Mous; Michael Roost Clausen; Peter Johnson; Kim M. Linton; Martine E. D. Chamuleau; David J. Lewis; Anna Sureda Balari; David Cunningham; Roberto S. Oliveri; Dena DeMarco; Brian Elliott; Kuo-mei Chen; Pieternella J. Lugtenburg

doi:10.1016/j.annonc.2021.05.546

O17-1 Subcutaneous (SC) epcoritamab induces complete responses across R/R B-cell NHL subtypes: Updated dose-escalation data

Martin Hutchings, Rogier Mous, Michael Roost Clausen, Peter Johnson, Kim M. Linton, Martine E. D. Chamuleau, David J. Lewis, Anna Sureda Balari, David Cunningham, Roberto S. Oliveri, Dena DeMarco, Brian Elliott, Kuo-mei Chen, Pieternella J. Lugtenburg

University of Southampton

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	S292-S292
Number of pages	1
Journal	Annals of Oncology
Volume	32
DOIs	https://doi.org/10.1016/j.annonc.2021.05.546
Publication status	Published - 26 Jul 2021

Research Beacons, Institutes and Platforms

Manchester Cancer Research Centre

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.annonc.2021.05.546

Cite this

Hutchings, M., Mous, R., Clausen, M. R., Johnson, P., Linton, K. M., Chamuleau, M. E. D., Lewis, D. J., Balari, A. S., Cunningham, D., Oliveri, R. S., DeMarco, D., Elliott, B., Chen, K., & Lugtenburg, P. J. (2021). O17-1 Subcutaneous (SC) epcoritamab induces complete responses across R/R B-cell NHL subtypes: Updated dose-escalation data. Annals of Oncology, 32, S292-S292. https://doi.org/10.1016/j.annonc.2021.05.546

@article{8a703acf761a43b0a5dc7cdc1c31ac9e,

title = "O17-1 Subcutaneous (SC) epcoritamab induces complete responses across R/R B-cell NHL subtypes: Updated dose-escalation data",

author = "Martin Hutchings and Rogier Mous and Clausen, {Michael Roost} and Peter Johnson and Linton, {Kim M.} and Chamuleau, {Martine E. D.} and Lewis, {David J.} and Balari, {Anna Sureda} and David Cunningham and Oliveri, {Roberto S.} and Dena DeMarco and Brian Elliott and Kuo-mei Chen and Lugtenburg, {Pieternella J.}",

year = "2021",

month = jul,

day = "26",

doi = "10.1016/j.annonc.2021.05.546",

language = "English",

volume = "32",

pages = "S292--S292",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier BV",

}

Hutchings, M, Mous, R, Clausen, MR, Johnson, P, Linton, KM, Chamuleau, MED, Lewis, DJ, Balari, AS, Cunningham, D, Oliveri, RS, DeMarco, D, Elliott, B, Chen, K & Lugtenburg, PJ 2021, 'O17-1 Subcutaneous (SC) epcoritamab induces complete responses across R/R B-cell NHL subtypes: Updated dose-escalation data', Annals of Oncology, vol. 32, pp. S292-S292. https://doi.org/10.1016/j.annonc.2021.05.546

TY - JOUR

T1 - O17-1 Subcutaneous (SC) epcoritamab induces complete responses across R/R B-cell NHL subtypes: Updated dose-escalation data

AU - Hutchings, Martin

AU - Mous, Rogier

AU - Clausen, Michael Roost

AU - Johnson, Peter

AU - Linton, Kim M.

AU - Chamuleau, Martine E. D.

AU - Lewis, David J.

AU - Balari, Anna Sureda

AU - Cunningham, David

AU - Oliveri, Roberto S.

AU - DeMarco, Dena

AU - Elliott, Brian

AU - Chen, Kuo-mei

AU - Lugtenburg, Pieternella J.

PY - 2021/7/26

Y1 - 2021/7/26

UR - https://www.mendeley.com/catalogue/4cd51a75-2691-3f19-a1d6-8932bdbce63b/

U2 - 10.1016/j.annonc.2021.05.546

DO - 10.1016/j.annonc.2021.05.546

M3 - Article

SN - 0923-7534

VL - 32

SP - S292-S292

JO - Annals of Oncology

JF - Annals of Oncology

ER -

O17-1 Subcutaneous (SC) epcoritamab induces complete responses across R/R B-cell NHL subtypes: Updated dose-escalation data

Research Beacons, Institutes and Platforms

UN SDGs

Access to Document

Other files and links

Cite this